Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brugnoni, D
Right arrow Articles by Airo, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brugnoni, D
Right arrow Articles by Airo, P
Haematologica, Vol 80, Issue 5, 440-442
Copyright © 1995 by Ferrata Storti Foundation


Journal Article

Study of CD40 ligand expression in B-cell chronic lymphocytic leukemia

D Brugnoni, G Rossi, A Tucci, R Cattaneo, and P Airo

Servizio di Immunologia Clinica, Spedali Civili di Brescia, Italy.

CD40 ligand (CD40L) is a membrane molecule that plays a key role in T cell-B cell cooperation, providing B cells the helper signals needed for activation, proliferation, differentiation and prevention of apoptosis. Patients with B-cell chronic lymphocytic leukemia (B-CLL) were studied to verify the following hypotheses: a) whether defective CD40L expression on activated T cells could account for deficient helper signals and therefore for hypogammaglobulinemia; b) whether aberrant CD40L expression on B cells could be a mechanism by which leukemic cells stimulate themselves via CD40 to escape apoptosis. Results showed physiological expression of CD40L on in vitro activated CD4+ cells, while this expression was absent on fresh and activated B cells. Abnormalities in CD40/CD40L interaction do not seem to play a role either in the pathogenesis of hypogammaglobulinemia or in lymphocyte accumulation in B-CLL.


This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Szomolanyi-Tsuda, J. D. Brien, J. E. Dorgan, R. M. Welsh, and R. L. Garcea
The Role of CD40-CD154 Interaction in Antiviral T Cell-Independent IgG Responses
J. Immunol., June 1, 2000; 164(11): 5877 - 5882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Knorr, C. Amrehn, H. Seeberger, A. Rosenwald, S. Stilgenbauer, G. Ott, H.-K. Muller Hermelink, and A. Greiner
Expression of Costimulatory Molecules in Low-Grade Mucosa-Associated Lymphoid Tissue-Type Lymphomas in Vivo
Am. J. Pathol., December 1, 1999; 155(6): 2019 - 2027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. J. Schattner, J. Mascarenhas, I. Reyfman, M. Koshy, C. Woo, S. M. Friedman, and M. K. Crow
Chronic Lymphocytic Leukemia B Cells Can Express CD40 Ligand and Demonstrate T-Cell Type Costimulatory Capacity
Blood, April 15, 1998; 91(8): 2689 - 2697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 1995 by the Ferrata Storti Foundation.